Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website
HSR&D In Progress

Summer 2016

In this Issue: Improving the Safety of Prescription Opioid Use among Veterans » Table of Contents


Effects of VHA Opioid Policy on Prescribing and Patient-Centered Outcomes

Ongoing Study

Opioid analgesics are the most commonly prescribed medications for chronic pain. However, an emerging public health epidemic of opioid-related harms – especially abuse and overdose – has triggered a new era in opioid attitudes and policies, in which opioid prescribing trends are being actively reversed. VA has been a national leader in pain management and has recently implemented the Opioid Safety Initiative (aims to increase use of opioid risk management tools and decrease high-risk prescribing practices) and mandatory written informed consent for long-term opioid therapy. These initiatives are anticipated to substantially reduce rates and intensity of opioid prescribing in VA. The main objective of this ongoing HSR&D study (July 2015 - June 2019) is to understand patient-centered outcomes of opioid prescribing changes among Veterans treated with long-term opioids for chronic pain.

A nationally representative sample of VA primary care patients receiving long-term opioid therapy (n= 13,675) will be invited to participate in a mailed survey, in order to collect longitudinal patient-reported pain outcomes data. Specific aims are to:

  • Examine the relationship between changes in prescribed opioids and changes in patient-reported pain and quality-of-life (QOL) outcomes; and
  • Identify any associations of patient, provider, and facility factors with changes in patient-reported pain and QOL, primarily through their influence on opioid prescribing and use of non-pharmacological pain therapies.

Patients are asked to complete brief questionnaires at three time points during the study: baseline, 12 months, and 24 months. Questionnaires assess pain-related function and health-related QOL as the primary outcomes, and evaluate pain characteristics, patient perceptions of care, and use of non-pharmacological therapies as covariates. VA administrative data will be used to assess patient use of pain-related health services and patient, provider, and facility covariates. Prospective patient-reported survey data will be merged with administrative data for analyses to address the specific aims.

Thus far, a pilot survey wave has been completed with a 71% response rate (355 respondents/498 contacted). The main baseline survey mailing is in progress.

Impact

Study findings will contribute to identifying successful approaches and targeting potential gaps in VA efforts to achieve patient-centered pain management and opioid safety goals.

View study abstract

Principal Investigator: Erin Krebs, MD, MPH, is part of HSR&D's Center for Chronic Disease Outcomes Research (CCDOR) in Minneapolis, MN.

Previous | Next



Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.